FAS Wealth Partners’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.94M Buy
109,371
+13,050
+14% +$439K 0.21% 101
2026
Q1
$3.46M Hold
96,321
0.22% 101
2025
Q4
$1.91M Hold
96,321
0.12% 131
2025
Q3
$1.76M Buy
96,321
+6,900
+8% +$114K 0.12% 132
2025
Q2
$1.41M Buy
89,421
+400
+0.4% +$5.09K 0.1% 135
2025
Q1
$1.13M Buy
89,021
+28,518
+47% +$448K 0.09% 141
2024
Q4
$1.33M Buy
60,503
+2,282
+4% +$48K 0.11% 130
2024
Q3
$1.04M Buy
58,221
+4,095
+8% +$65.6K 0.08% 146
2024
Q2
$869K Buy
54,126
+2,308
+4% +$36.4K 0.08% 149
2024
Q1
$770K Sell
51,818
-3,050
-6% -$48.6K 0.07% 161
2023
Q4
$980K Buy
54,868
+14,770
+37% +$240K 0.09% 144
2023
Q3
$766K Buy
+40,098
New +$694K 0.08% 157

Other funds holding CLMT

FAS Wealth Partners's CLMT Position: Q2 2026 in Review

FAS Wealth Partners increased its Calumet Specialty Products (CLMT) stake by 14% in Q2 2026, buying an estimated $439K and bringing the position to 109,371 shares worth $3.94M. The position accounts for 0.21% of the portfolio, ranked #101.

FAS Wealth Partners first reported a position in CLMT in Q3 2023 and has held it in 12 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • FAS Wealth Partners held 109,371 shares of Calumet Specialty Products worth $3.94M as of Q2 2026.
  • FAS Wealth Partners bought 13,050 Calumet Specialty Products shares in Q2 2026, an estimated $439K.
  • Calumet Specialty Products made up 0.21% of FAS Wealth Partners's portfolio in Q2 2026, its #101 holding.
  • FAS Wealth Partners first reported a position in Calumet Specialty Products in Q3 2023 and has held it in 12 quarters since.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on FAS Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.